Proteomic profiling in multiple sclerosis clinical courses reveals potential biomarkers of neurodegeneration.
The aim of our project was to perform an exploratory analysis of the cerebrospinal fluid (CSF) proteomic profiles of Multiple Sclerosis (MS) patients, collected in different phases of their clinical course, in order to investigate the existence of peculiar profiles characterizing the different MS ph...
Guardado en:
Autores principales: | Maria Liguori, Antonio Qualtieri, Carla Tortorella, Vita Direnzo, Angelo Bagalà, Mariangela Mastrapasqua, Patrizia Spadafora, Maria Trojano |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1b6ed861133146cdb321a856a5257425 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
por: Damiano Paolicelli, et al.
Publicado: (2009) -
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study.
por: Pietro Iaffaldano, et al.
Publicado: (2012) -
Digital Biomarkers in Multiple Sclerosis
por: Anja Dillenseger, et al.
Publicado: (2021) -
Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis
por: Julien Bourel, et al.
Publicado: (2021) -
CSF proteome in multiple sclerosis subtypes related to brain lesion transcriptomes
por: Maria L. Elkjaer, et al.
Publicado: (2021)